Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists

BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) such as dabigatran or rivaroxaban are alternatives to vitamin K antagonists (VKAs) for prevention of stroke and systemic embolism in patients with atrial fibrillation (AF) and atrial flutter (AFL). Incidences of risk factors for left a...

Full description

Saved in:
Bibliographic Details
Published in:Eur J Med Res
Main Authors: Reers, Stefan, Agdirlioglu, Tolga, Kellner, Michael, Borowski, Matthias, Thiele, Holger, Waltenberger, Johannes, Reppel, Michael
Format: Artigo
Language:Inglês
Published: BioMed Central 2016
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5073429/
https://ncbi.nlm.nih.gov/pubmed/27769294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40001-016-0235-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items